Technical Analysis for SRNE - Sorrento Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 3.64 -4.21% -0.16
SRNE closed down 4.21 percent on Friday, May 17, 2019, on 21 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical SRNE trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Earnings Movers Other 0.00%
50 DMA Support Bullish -4.21%
Bollinger Band Squeeze Range Contraction -4.21%
NR7 Range Contraction -4.21%
Earnings Movers Other -4.21%
BB Squeeze + Upper Band Touch Range Contraction -4.21%
Upper Bollinger Band Touch Strength -4.21%

Older signals for SRNE ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Sorrento Therapeutics, Inc., a development stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel and proprietary biotherapeutics for the treatment of cancer, inflammation, metabolic, and infectious diseases in the United States. The company's G-MAB, a human antibody library platform, facilitates the rapid identification and isolation of highly specific antibody therapeutic product candidates that bind to disease targets appropriate for antibody therapy. Its human antibody library technology is used to construct large human antibody libraries. It has license agreement with OPKO Health, Inc. to develop, manufacture, use, market, sell, offer to sell, import, and export certain products related to the development, manufacture, marketing, and sale of drugs for ophthalmological indications. Sorrento Therapeutics, Inc. is based in San Diego, California.
Medicine Biotechnology Health Biopharmaceutical Cancer Biology Immunology Disease Infectious Diseases Treatment Of Cancer Immune System Inflammation Antibody Monoclonal Antibody Antibody Therapy
Is SRNE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.25
52 Week Low 1.8
Average Volume 3,141,395
200-Day Moving Average 3.5546
50-Day Moving Average 3.8168
20-Day Moving Average 3.691
10-Day Moving Average 3.691
Average True Range 0.2817
ADX 16.63
+DI 25.0057
-DI 17.4129
Chandelier Exit (Long, 3 ATRs ) 3.3149
Chandelier Exit (Short, 3 ATRs ) 4.2651
Upper Bollinger Band 3.8772
Lower Bollinger Band 3.5048
Percent B (%b) 0.36
BandWidth 10.089407
MACD Line -0.0207
MACD Signal Line -0.0256
MACD Histogram 0.0049
Fundamentals Value
Market Cap 251.05 Million
Num Shares 69 Million
EPS -0.66
Price-to-Earnings (P/E) Ratio -5.53
Price-to-Sales 10.91
Price-to-Book 1.87
PEG Ratio -0.06
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.99
Resistance 3 (R3) 4.01 3.93 3.93
Resistance 2 (R2) 3.93 3.84 3.91 3.91
Resistance 1 (R1) 3.78 3.78 3.74 3.76 3.89
Pivot Point 3.70 3.70 3.68 3.68 3.70
Support 1 (S1) 3.55 3.61 3.51 3.53 3.39
Support 2 (S2) 3.47 3.55 3.45 3.37
Support 3 (S3) 3.32 3.47 3.35
Support 4 (S4) 3.30